Hologic Inc has received an approvable letter from the Food and Drug Administration (FDA) for a Premarket Approval (PMA) supplement which covers the use of the Company's proprietary DirectRay ...

Hologic is rallying $1.50, or 14.4 percent, to $11.95, after the company received final approval of a pre-market approval supplement for its Lorad Selenia digital mammography system from the Food and ...

Hologic Inc has received final approval from the Food and Drug Administration (FDA) for a Premarket Approval (PMA) supplement which covers the use of the Company''''s proprietary DirectRay ...

Hologic has released more data bolstering the use of its mammography AI for detecting breast cancer. (thomasandreas/iStock/Getty Images Plus) Hologic has put forward ...

Breast cancer continues to be a significant global health challenge and the leading cause of cancer-related deaths among women. Artificial Intelligence is playing an increasingly vital role in ...

Hologic touted studies of AI's potential to help detect breast cancer amid long-running shortages of trained radiologists. (thomasandreas/iStock/Getty Images Plus ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...

CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide ...